FMP

FMP

Enter

PTIX - Protagenic Therapeut...

photo-url-https://images.financialmodelingprep.com/symbol/PTIX.png

Protagenic Therapeutics, Inc.

PTIX

NASDAQ

Protagenic Therapeutics, Inc., a biopharmaceutical company, engages in the discovery and development of therapeutics to treat stress-related neuropsychiatric and mood disorders. Its lead compound is PT00114, a synthetic form of teneurin carboxy-terminal associated peptide, an endogenous brain signaling peptide that can dampen overactive stress responses. The company is based in New York, New York.

0.424 USD

0.0203 (4.78%)

Terminal Value

Growth In Perpetuity Method

Long Term Growth Rate

Wacc

7.3

Free Cash Flow T1

-4.16M

Terminal Value

-78.54M

Present Terminal Value

-55.21M

FMP

FMP

Financial Modeling Prep API provides real time stock price, company financial statements, major index prices, stock historical data, forex real time rate and cryptocurrencies. Financial Modeling Prep stock price API is in real time, the company reports can be found in quarter or annual format, and goes back 30 years in history.
twitterlinkedinfacebookinstagram
2017-2024 © Financial Modeling Prep